← sources

[United States/medicaldaily.com] FDA Approves the First Eye - Specific Bevacizumab for Wet Macular Degeneration After Two Decades of Off - Label Use

source: gdelt (gdelt:amd)published 2026-08-04 03:45ingested 2026-08-04 08:49

retained text

No document body was retained for this record — only its metadata was stored.

document fetched 2026-08-04 08:49 · canonical https://medicaldaily.com/fda-approves-lytenava-ophthalmic-bevacizumab-wet-amd-476794